n-(3-(aminomethyl)benzyl)acetamidine has been researched along with arachidonic acid in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bend, JR; McCormack, DG; Mehta, S; Webb, CD; Weicker, S; Yaghi, A; Zeldin, DC | 1 |
Cianchi, F; Cortesini, C; Di Felice, A; Fabbroni, V; Fantappiè, O; Lasagna, N; Masini, E; Mazzanti, R; Messerini, L; Perigli, G; Perna, F; Sardi, I | 1 |
Inada, T; Kambara, T; Kubo, K; Shingu, K | 1 |
3 other study(ies) available for n-(3-(aminomethyl)benzyl)acetamidine and arachidonic acid
Article | Year |
---|---|
Excess nitric oxide decreases cytochrome P-450 2J4 content and P-450-dependent arachidonic acid metabolism in lungs of rats with acute pneumonia.
Topics: Acute Disease; Amidines; Amino Acid Sequence; Animals; Arachidonic Acid; Benzylamines; Blood Pressure; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 2; Enzyme Inhibitors; Hydroxyeicosatetraenoic Acids; Lung; Male; Molecular Sequence Data; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Pneumonia; Rats; Rats, Sprague-Dawley | 2004 |
Cyclooxygenase-2 activation mediates the proangiogenic effect of nitric oxide in colorectal cancer.
Topics: Aged; Aged, 80 and over; Amidines; Arachidonic Acid; Benzylamines; Blotting, Northern; Blotting, Western; Cell Division; Cell Line, Tumor; Cell Survival; Colorectal Neoplasms; Cyclic AMP; Cyclic GMP; Cyclooxygenase 2; Dinoprostone; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunohistochemistry; Isoenzymes; Lipopolysaccharides; Male; Membrane Proteins; Microcirculation; Middle Aged; Models, Biological; Neovascularization, Pathologic; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Platelet Endothelial Cell Adhesion Molecule-1; Prostaglandin-Endoperoxide Synthases; Treatment Outcome; Up-Regulation; Vascular Endothelial Growth Factor A | 2004 |
Propofol suppresses prostaglandin E(2) production in human peripheral monocytes.
Topics: Amidines; Arachidonic Acid; Arginine; Benzylamines; Biocatalysis; Cell Survival; Cyclooxygenase 1; Cyclooxygenase 2; Dinoprostone; Enzyme Inhibitors; Humans; Interleukin-10; Lipopolysaccharides; Monocytes; Nitric Oxide; Nitric Oxide Synthase Type II; Propofol; Thromboxane B2; Tumor Necrosis Factor-alpha | 2009 |